Home › Funds › Vident Advisory, LLC › JNJ

Vident Advisory, LLC position in JNJ

JOHNSON JOHNSON · Health Care

Vident Advisory, LLC reported holding 208,589 shares of JNJ (JOHNSON JOHNSON) in its Q2 2026 13F filing — a position valued at US$53.0M, representing 0.40% of its reported portfolio and ranking #48 among its reported holdings. Vident Advisory, LLC has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)208.59K sh
Reported value held$52.98M
Portfolio Weight0.40%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Vident Advisory, LLC's JNJ position evolved

Vident Advisory, LLC first disclosed a stake in JNJ in Q3 2023 at 255,524 shares (US$39.8M). The position peaked in Q1 2024 at 387,116 shares, worth US$61.2M. Across 12 filings, Vident Advisory, LLC increased the stake 9 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 208,589 shares valued at US$53.0M — an increase of 30,751 shares quarter over quarter.. Notable position changes include a 33% increase in Q1 2024 (shares fell 8% over the following quarter), a 68% trim in Q2 2024 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 255.52K $39.80M New
Q4 2023 291.84K $45.74M Add
Q1 2024 387.12K $61.24M Add
Q2 2024 124.31K $18.17M Reduce
Q3 2024 115.26K $18.68M Reduce
Q4 2024 142.29K $20.58M Add
Q1 2025 148.16K $24.57M Add
Q2 2025 159.04K $24.29M Add
Q3 2025 163.41K $30.30M Add
Q4 2025 172.85K $35.77M Add
Q1 2026 177.84K $43.47M Add
Q2 2026 208.59K $52.98M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Vident Advisory, LLC held JNJ?

Vident Advisory, LLC has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Vident Advisory, LLC's current position in JNJ?

As of Q2 2026, Vident Advisory, LLC holds 208.59K shares of JNJ (JOHNSON JOHNSON), valued at $52.98M, representing 0.40% of its reported portfolio and ranking #48.

Has Vident Advisory, LLC been buying or selling JNJ?

In the latest 13F filing (Q2 2026), Vident Advisory, LLC increased its position in JNJ. The position peaked in Q1 2024 at 387.12K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.